Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.65558277 |
2 | sarcomere organization (GO:0045214) | 5.55025948 |
3 | cardiac myofibril assembly (GO:0055003) | 5.51611112 |
4 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.48218198 |
5 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.43602554 |
6 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.35926809 |
7 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.28586098 |
8 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.05689076 |
9 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.98654469 |
10 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.98247683 |
11 | plasma membrane repair (GO:0001778) | 4.91565020 |
12 | cardiac muscle contraction (GO:0060048) | 4.86199391 |
13 | myofibril assembly (GO:0030239) | 4.84866679 |
14 | regulation of actin filament-based movement (GO:1903115) | 4.71383404 |
15 | cell communication by electrical coupling (GO:0010644) | 4.58156519 |
16 | cell communication involved in cardiac conduction (GO:0086065) | 4.48999925 |
17 | regulation of cell communication by electrical coupling (GO:0010649) | 4.42809785 |
18 | tricarboxylic acid cycle (GO:0006099) | 4.30345507 |
19 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.28991280 |
20 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.21938531 |
21 | regulation of membrane repolarization (GO:0060306) | 4.13573304 |
22 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.11372707 |
23 | muscle filament sliding (GO:0030049) | 4.10094811 |
24 | actin-myosin filament sliding (GO:0033275) | 4.10094811 |
25 | relaxation of cardiac muscle (GO:0055119) | 4.08870574 |
26 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.88028129 |
27 | actomyosin structure organization (GO:0031032) | 3.84936132 |
28 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.81940553 |
29 | potassium ion import (GO:0010107) | 3.81932919 |
30 | cardiac muscle cell development (GO:0055013) | 3.80852669 |
31 | sodium ion export (GO:0071436) | 3.78055024 |
32 | regulation of striated muscle contraction (GO:0006942) | 3.74042258 |
33 | regulation of relaxation of muscle (GO:1901077) | 3.72467300 |
34 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.71725146 |
35 | striated muscle contraction (GO:0006941) | 3.71046093 |
36 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.65728016 |
37 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.65301445 |
38 | cerebellar granule cell differentiation (GO:0021707) | 3.62795462 |
39 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.62007914 |
40 | cardiac muscle hypertrophy (GO:0003300) | 3.60903119 |
41 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.60774091 |
42 | carnitine shuttle (GO:0006853) | 3.60672903 |
43 | heart trabecula formation (GO:0060347) | 3.60094646 |
44 | regulation of the force of heart contraction (GO:0002026) | 3.57292792 |
45 | negative regulation of protein localization to cell surface (GO:2000009) | 3.54902656 |
46 | cardiac cell development (GO:0055006) | 3.54416964 |
47 | adult heart development (GO:0007512) | 3.53058101 |
48 | regulation of skeletal muscle contraction (GO:0014819) | 3.52298706 |
49 | actin-mediated cell contraction (GO:0070252) | 3.47147483 |
50 | regulation of cardiac muscle contraction (GO:0055117) | 3.43856143 |
51 | striated muscle hypertrophy (GO:0014897) | 3.43543990 |
52 | cardiac conduction (GO:0061337) | 3.39926200 |
53 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.39820291 |
54 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.39820291 |
55 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.39673830 |
56 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.34449351 |
57 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.33111377 |
58 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.31399936 |
59 | cellular potassium ion homeostasis (GO:0030007) | 3.30036206 |
60 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.27816530 |
61 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.26104051 |
62 | creatine metabolic process (GO:0006600) | 3.26091300 |
63 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.26059010 |
64 | cardiac muscle cell action potential (GO:0086001) | 3.25481525 |
65 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.23656667 |
66 | regulation of sarcomere organization (GO:0060297) | 3.20558833 |
67 | fatty acid transmembrane transport (GO:1902001) | 3.15995609 |
68 | cell-substrate adherens junction assembly (GO:0007045) | 3.14736089 |
69 | focal adhesion assembly (GO:0048041) | 3.14736089 |
70 | detection of calcium ion (GO:0005513) | 3.14184188 |
71 | glutamate secretion (GO:0014047) | 3.10965982 |
72 | adherens junction assembly (GO:0034333) | 3.08204654 |
73 | regulation of heart rate (GO:0002027) | 3.07866209 |
74 | negative regulation of potassium ion transport (GO:0043267) | 3.04858071 |
75 | positive regulation of cation channel activity (GO:2001259) | 3.03525671 |
76 | muscle tissue morphogenesis (GO:0060415) | 3.00794286 |
77 | membrane repolarization (GO:0086009) | 2.99435722 |
78 | regulation of coenzyme metabolic process (GO:0051196) | 2.98110096 |
79 | regulation of cofactor metabolic process (GO:0051193) | 2.98110096 |
80 | membrane repolarization during action potential (GO:0086011) | 2.96829679 |
81 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.96755095 |
82 | response to pheromone (GO:0019236) | 2.96067914 |
83 | activation of protein kinase A activity (GO:0034199) | 2.96022649 |
84 | regulation of heart contraction (GO:0008016) | 2.95102287 |
85 | carnitine transmembrane transport (GO:1902603) | 2.94081985 |
86 | muscle hypertrophy (GO:0014896) | 2.93096206 |
87 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.92072924 |
88 | positive regulation of potassium ion transport (GO:0043268) | 2.91491513 |
89 | NADH metabolic process (GO:0006734) | 2.91145309 |
90 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.90203075 |
91 | relaxation of muscle (GO:0090075) | 2.88260832 |
92 | muscle contraction (GO:0006936) | 2.87952537 |
93 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.87042224 |
94 | skeletal muscle contraction (GO:0003009) | 2.87035267 |
95 | synaptic vesicle exocytosis (GO:0016079) | 2.86830565 |
96 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.84942597 |
97 | cellular sodium ion homeostasis (GO:0006883) | 2.83377527 |
98 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.82295006 |
99 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.81697431 |
100 | actin filament-based movement (GO:0030048) | 2.80390061 |
101 | growth hormone secretion (GO:0030252) | 2.80077924 |
102 | synaptic vesicle maturation (GO:0016188) | 2.79562528 |
103 | cardiac muscle adaptation (GO:0014887) | 2.78025556 |
104 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.78025556 |
105 | muscle hypertrophy in response to stress (GO:0003299) | 2.78025556 |
106 | relaxation of smooth muscle (GO:0044557) | 2.76468104 |
107 | cellular response to epinephrine stimulus (GO:0071872) | 2.75782924 |
108 | amino-acid betaine transport (GO:0015838) | 2.73000545 |
109 | carnitine transport (GO:0015879) | 2.73000545 |
110 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.72569038 |
111 | positive regulation of sodium ion transport (GO:0010765) | 2.72107920 |
112 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.71225889 |
113 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.71225889 |
114 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.71165828 |
115 | regulation of cation channel activity (GO:2001257) | 2.70532114 |
116 | positive regulation of ion transmembrane transporter activity (GO:0032414) | 2.70153823 |
117 | positive regulation of heart contraction (GO:0045823) | 2.69061873 |
118 | muscle system process (GO:0003012) | 2.66707174 |
119 | neuronal action potential propagation (GO:0019227) | 2.65269854 |
120 | regulation of cardioblast differentiation (GO:0051890) | 2.65059354 |
121 | negative regulation of fatty acid transport (GO:2000192) | 2.63376914 |
122 | positive regulation of synapse maturation (GO:0090129) | 2.61791554 |
123 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.61041945 |
124 | cellular response to monoamine stimulus (GO:0071868) | 2.57231135 |
125 | cellular response to catecholamine stimulus (GO:0071870) | 2.57231135 |
126 | layer formation in cerebral cortex (GO:0021819) | 2.56538842 |
127 | response to muscle activity (GO:0014850) | 2.56298199 |
128 | skeletal muscle fiber development (GO:0048741) | 2.53923543 |
129 | regulation of early endosome to late endosome transport (GO:2000641) | 2.53318960 |
130 | regulation of synaptic vesicle transport (GO:1902803) | 2.53118087 |
131 | cGMP-mediated signaling (GO:0019934) | 2.52822491 |
132 | protein targeting to plasma membrane (GO:0072661) | 2.47793846 |
133 | cell-substrate junction assembly (GO:0007044) | 2.45770896 |
134 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.44585304 |
135 | positive regulation of receptor recycling (GO:0001921) | 2.43124328 |
136 | response to epinephrine (GO:0071871) | 2.42719990 |
137 | stress fiber assembly (GO:0043149) | 2.41577792 |
138 | striated muscle adaptation (GO:0014888) | 2.37192020 |
139 | fructose metabolic process (GO:0006000) | 2.35429591 |
140 | positive regulation of muscle hypertrophy (GO:0014742) | 2.34328544 |
141 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.34328544 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.60467769 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.95728075 |
3 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.67991671 |
4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.47801139 |
5 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.35399859 |
6 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.32958730 |
7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.27325786 |
8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.14675571 |
9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.14675571 |
10 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.08581231 |
11 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.08581231 |
12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.01703704 |
13 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.99996851 |
14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.99050263 |
15 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.94304847 |
16 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.91721378 |
17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.83896826 |
18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.83534872 |
19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.82659113 |
20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.82194785 |
21 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.76715455 |
22 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.70710862 |
23 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.64221078 |
24 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.63183934 |
25 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.62110226 |
26 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.59244988 |
27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.58362663 |
28 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.57926101 |
29 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57386424 |
30 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.54519875 |
31 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.53580934 |
32 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.52675123 |
33 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.51856754 |
34 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.50550135 |
35 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.50323072 |
36 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.48685538 |
37 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.47382076 |
38 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.46331200 |
39 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.44542273 |
40 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.44288785 |
41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.43758642 |
42 | KDM2B_26808549_Chip-Seq_K562_Human | 1.38735639 |
43 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.37493952 |
44 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.31791861 |
45 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.31783738 |
46 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.29138309 |
47 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.26219601 |
48 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.26069709 |
49 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.24062535 |
50 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.23790994 |
51 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23052419 |
52 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.22671026 |
53 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.22384513 |
54 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.19820748 |
55 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.19182977 |
56 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.18845800 |
57 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.17681902 |
58 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.17026278 |
59 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.16793140 |
60 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.16776959 |
61 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.16748509 |
62 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.16293920 |
63 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16194037 |
64 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.14647045 |
65 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.14074233 |
66 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.12846706 |
67 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.12781918 |
68 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11588331 |
69 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.10377818 |
70 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.09301608 |
71 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.08859840 |
72 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.08720981 |
73 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.08583259 |
74 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.06519574 |
75 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.06512938 |
76 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.06296160 |
77 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05625414 |
78 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.05455094 |
79 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.00910702 |
80 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.00703000 |
81 | * AR_19668381_ChIP-Seq_PC3_Human | 0.99577389 |
82 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.99466314 |
83 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99406030 |
84 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.99258232 |
85 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.99239603 |
86 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.99126505 |
87 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.98728344 |
88 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.98235175 |
89 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.97348270 |
90 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97306767 |
91 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97151835 |
92 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.97022026 |
93 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96676660 |
94 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.96152919 |
95 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95982662 |
96 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95770261 |
97 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.95044542 |
98 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.94736420 |
99 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.94706273 |
100 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.94547641 |
101 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94273177 |
102 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.93823869 |
103 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.93703846 |
104 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.92882144 |
105 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92669222 |
106 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.91398219 |
107 | TP53_16413492_ChIP-PET_HCT116_Human | 0.90839512 |
108 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90011833 |
109 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89561939 |
110 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.89337059 |
111 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89332297 |
112 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89224699 |
113 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89088314 |
114 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.88219382 |
115 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.87397759 |
116 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.87193149 |
117 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86868288 |
118 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85578373 |
119 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.85548056 |
120 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.84716307 |
121 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84079372 |
122 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.83837393 |
123 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.83518528 |
124 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.82019129 |
125 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.81236776 |
126 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.81123324 |
127 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.80820890 |
128 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.77473367 |
129 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.76025263 |
130 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75759861 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002837_dystrophic_cardiac_calcinosis | 5.43400433 |
2 | MP0004084_abnormal_cardiac_muscle | 4.70031462 |
3 | MP0000751_myopathy | 4.42477787 |
4 | MP0003646_muscle_fatigue | 4.35974313 |
5 | MP0004215_abnormal_myocardial_fiber | 4.09582236 |
6 | MP0004036_abnormal_muscle_relaxation | 3.74125691 |
7 | MP0004145_abnormal_muscle_electrophysio | 3.34020485 |
8 | MP0005330_cardiomyopathy | 2.98159658 |
9 | MP0000749_muscle_degeneration | 2.97848558 |
10 | MP0003137_abnormal_impulse_conducting | 2.63110592 |
11 | MP0004087_abnormal_muscle_fiber | 2.60954858 |
12 | MP0002972_abnormal_cardiac_muscle | 2.55588596 |
13 | MP0008775_abnormal_heart_ventricle | 2.48410094 |
14 | MP0004484_altered_response_of | 2.42185888 |
15 | MP0005620_abnormal_muscle_contractility | 2.31863395 |
16 | MP0006138_congestive_heart_failure | 2.27294462 |
17 | MP0004130_abnormal_muscle_cell | 2.26802032 |
18 | MP0002106_abnormal_muscle_physiology | 2.09070698 |
19 | MP0001544_abnormal_cardiovascular_syste | 2.07779894 |
20 | MP0005385_cardiovascular_system_phenoty | 2.07779894 |
21 | MP0004085_abnormal_heartbeat | 2.05626465 |
22 | MP0000747_muscle_weakness | 1.99776568 |
23 | MP0010630_abnormal_cardiac_muscle | 1.97755265 |
24 | MP0000750_abnormal_muscle_regeneration | 1.92569063 |
25 | MP0009046_muscle_twitch | 1.91973214 |
26 | MP0004859_abnormal_synaptic_plasticity | 1.90441526 |
27 | MP0003880_abnormal_central_pattern | 1.90269687 |
28 | MP0002269_muscular_atrophy | 1.89966038 |
29 | MP0004233_abnormal_muscle_weight | 1.80160027 |
30 | MP0005369_muscle_phenotype | 1.75611352 |
31 | MP0000759_abnormal_skeletal_muscle | 1.72764166 |
32 | MP0008569_lethality_at_weaning | 1.67622079 |
33 | MP0005409_darkened_coat_color | 1.64109356 |
34 | MP0005423_abnormal_somatic_nervous | 1.60358213 |
35 | MP0005451_abnormal_body_composition | 1.60238637 |
36 | MP0004043_abnormal_pH_regulation | 1.57883352 |
37 | MP0005623_abnormal_meninges_morphology | 1.56978653 |
38 | MP0004510_myositis | 1.52774743 |
39 | MP0000013_abnormal_adipose_tissue | 1.49654835 |
40 | MP0003828_pulmonary_edema | 1.45933065 |
41 | MP0003879_abnormal_hair_cell | 1.45643143 |
42 | MP0003635_abnormal_synaptic_transmissio | 1.43224302 |
43 | MP0002909_abnormal_adrenal_gland | 1.36573569 |
44 | MP0005666_abnormal_adipose_tissue | 1.31196178 |
45 | MP0000733_abnormal_muscle_development | 1.23196115 |
46 | MP0003950_abnormal_plasma_membrane | 1.20626648 |
47 | MP0002272_abnormal_nervous_system | 1.19767792 |
48 | MP0003221_abnormal_cardiomyocyte_apopto | 1.16526448 |
49 | MP0002332_abnormal_exercise_endurance | 1.15426964 |
50 | MP0003091_abnormal_cell_migration | 1.13954348 |
51 | MP0003279_aneurysm | 1.13541856 |
52 | MP0004270_analgesia | 1.13513967 |
53 | MP0003705_abnormal_hypodermis_morpholog | 1.11543492 |
54 | MP0006036_abnormal_mitochondrial_physio | 1.10858004 |
55 | MP0003329_amyloid_beta_deposits | 1.09409167 |
56 | MP0008004_abnormal_stomach_pH | 1.09285037 |
57 | MP0005375_adipose_tissue_phenotype | 1.08253008 |
58 | MP0000767_abnormal_smooth_muscle | 1.07875245 |
59 | MP0002127_abnormal_cardiovascular_syste | 1.07469038 |
60 | MP0005670_abnormal_white_adipose | 1.07386464 |
61 | MP0004147_increased_porphyrin_level | 1.06782720 |
62 | MP0009780_abnormal_chondrocyte_physiolo | 1.05810876 |
63 | MP0005167_abnormal_blood-brain_barrier | 1.04288575 |
64 | MP0008874_decreased_physiological_sensi | 1.04187454 |
65 | MP0002064_seizures | 1.02389648 |
66 | MP0000003_abnormal_adipose_tissue | 1.02357141 |
67 | MP0009745_abnormal_behavioral_response | 1.00433912 |
68 | MP0001440_abnormal_grooming_behavior | 0.99844522 |
69 | MP0010368_abnormal_lymphatic_system | 0.98820697 |
70 | MP0004185_abnormal_adipocyte_glucose | 0.98413655 |
71 | MP0005595_abnormal_vascular_smooth | 0.97800821 |
72 | MP0002234_abnormal_pharynx_morphology | 0.97263731 |
73 | MP0005165_increased_susceptibility_to | 0.95201997 |
74 | MP0005503_abnormal_tendon_morphology | 0.92621648 |
75 | MP0002108_abnormal_muscle_morphology | 0.90143196 |
76 | MP0004924_abnormal_behavior | 0.88065569 |
77 | MP0005386_behavior/neurological_phenoty | 0.88065569 |
78 | MP0002067_abnormal_sensory_capabilities | 0.87726126 |
79 | MP0001849_ear_inflammation | 0.87110282 |
80 | MP0000266_abnormal_heart_morphology | 0.86891713 |
81 | MP0004272_abnormal_basement_membrane | 0.85780600 |
82 | MP0000534_abnormal_ureter_morphology | 0.84541015 |
83 | MP0000230_abnormal_systemic_arterial | 0.83512935 |
84 | MP0005187_abnormal_penis_morphology | 0.82852962 |
85 | MP0002063_abnormal_learning/memory/cond | 0.82055068 |
86 | MP0008961_abnormal_basal_metabolism | 0.79798131 |
87 | MP0003045_fibrosis | 0.79515267 |
88 | MP0008438_abnormal_cutaneous_collagen | 0.79033614 |
89 | MP0000537_abnormal_urethra_morphology | 0.77590163 |
90 | MP0006035_abnormal_mitochondrial_morpho | 0.77539116 |
91 | MP0009384_cardiac_valve_regurgitation | 0.74847885 |
92 | MP0002971_abnormal_brown_adipose | 0.71971670 |
93 | MP0002734_abnormal_mechanical_nocicepti | 0.70778455 |
94 | MP0002896_abnormal_bone_mineralization | 0.70243871 |
95 | MP0003634_abnormal_glial_cell | 0.69879745 |
96 | MP0002089_abnormal_postnatal_growth/wei | 0.69610579 |
97 | MP0003123_paternal_imprinting | 0.69493327 |
98 | MP0004885_abnormal_endolymph | 0.69419297 |
99 | MP0000920_abnormal_myelination | 0.69131498 |
100 | MP0000343_altered_response_to | 0.68982488 |
101 | MP0002735_abnormal_chemical_nociception | 0.68955959 |
102 | MP0008260_abnormal_autophagy | 0.68414948 |
103 | MP0002572_abnormal_emotion/affect_behav | 0.67895073 |
104 | MP0003633_abnormal_nervous_system | 0.67599273 |
105 | MP0003690_abnormal_glial_cell | 0.64434587 |
106 | MP0001486_abnormal_startle_reflex | 0.63240424 |
107 | MP0005275_abnormal_skin_tensile | 0.62996370 |
108 | MP0003283_abnormal_digestive_organ | 0.62368567 |
109 | MP0005083_abnormal_biliary_tract | 0.62302019 |
110 | MP0002066_abnormal_motor_capabilities/c | 0.61986326 |
111 | MP0004142_abnormal_muscle_tone | 0.61752812 |
112 | MP0001299_abnormal_eye_distance/ | 0.60915527 |
113 | MP0003566_abnormal_cell_adhesion | 0.60846439 |
114 | MP0002128_abnormal_blood_circulation | 0.60083249 |
115 | MP0001958_emphysema | 0.59222044 |
116 | MP0002822_catalepsy | 0.58565101 |
117 | MP0005535_abnormal_body_temperature | 0.58202667 |
118 | MP0004858_abnormal_nervous_system | 0.57275917 |
119 | MP0001879_abnormal_lymphatic_vessel | 0.57233261 |
120 | MP0002184_abnormal_innervation | 0.56549464 |
121 | MP0003567_abnormal_fetal_cardiomyocyte | 0.56086126 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sudden death (HP:0001699) | 6.73360529 |
2 | Exercise-induced myalgia (HP:0003738) | 5.39446241 |
3 | Ventricular tachycardia (HP:0004756) | 5.34842849 |
4 | Nemaline bodies (HP:0003798) | 5.16504873 |
5 | Exercise-induced muscle cramps (HP:0003710) | 5.07887656 |
6 | Atrial fibrillation (HP:0005110) | 5.07698733 |
7 | Calf muscle hypertrophy (HP:0008981) | 4.97728202 |
8 | Bundle branch block (HP:0011710) | 4.92170974 |
9 | Muscle fiber splitting (HP:0003555) | 4.85611895 |
10 | Primary atrial arrhythmia (HP:0001692) | 4.73853376 |
11 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.71852474 |
12 | Hyporeflexia of lower limbs (HP:0002600) | 4.52588028 |
13 | Supraventricular tachycardia (HP:0004755) | 4.52121345 |
14 | Syncope (HP:0001279) | 4.51843797 |
15 | Supraventricular arrhythmia (HP:0005115) | 4.46613919 |
16 | Right ventricular cardiomyopathy (HP:0011663) | 4.29787273 |
17 | Ventricular fibrillation (HP:0001663) | 4.29641820 |
18 | Abnormality of the calf musculature (HP:0001430) | 4.29217946 |
19 | Myoglobinuria (HP:0002913) | 4.11865430 |
20 | Prolonged QT interval (HP:0001657) | 4.11266142 |
21 | Lipoatrophy (HP:0100578) | 3.91408531 |
22 | Subaortic stenosis (HP:0001682) | 3.86445780 |
23 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.86445780 |
24 | Heart block (HP:0012722) | 3.71978379 |
25 | Ventricular arrhythmia (HP:0004308) | 3.71638055 |
26 | Myotonia (HP:0002486) | 3.65041728 |
27 | Difficulty running (HP:0009046) | 3.59630683 |
28 | Dysmetric saccades (HP:0000641) | 3.54049331 |
29 | Abnormal atrioventricular conduction (HP:0005150) | 3.50604197 |
30 | EMG: myopathic abnormalities (HP:0003458) | 3.46735902 |
31 | Dilated cardiomyopathy (HP:0001644) | 3.32138582 |
32 | Atrioventricular block (HP:0001678) | 3.31139908 |
33 | Asymmetric septal hypertrophy (HP:0001670) | 3.29701027 |
34 | Palpitations (HP:0001962) | 3.27353851 |
35 | Atonic seizures (HP:0010819) | 3.21086084 |
36 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.19835293 |
37 | Increased connective tissue (HP:0009025) | 3.18240085 |
38 | Abnormal EKG (HP:0003115) | 3.00310287 |
39 | Aortic aneurysm (HP:0004942) | 2.98352370 |
40 | Round ear (HP:0100830) | 2.96607431 |
41 | Broad metatarsal (HP:0001783) | 2.90666066 |
42 | Distal arthrogryposis (HP:0005684) | 2.90491732 |
43 | Increased variability in muscle fiber diameter (HP:0003557) | 2.87150290 |
44 | Action tremor (HP:0002345) | 2.85606972 |
45 | Protrusio acetabuli (HP:0003179) | 2.77771544 |
46 | Febrile seizures (HP:0002373) | 2.71377048 |
47 | Myopathic facies (HP:0002058) | 2.69243268 |
48 | Muscle stiffness (HP:0003552) | 2.64855551 |
49 | Spinal rigidity (HP:0003306) | 2.63380421 |
50 | Ketoacidosis (HP:0001993) | 2.63095415 |
51 | Rhabdomyolysis (HP:0003201) | 2.60230370 |
52 | Difficulty climbing stairs (HP:0003551) | 2.56925475 |
53 | Cerebral aneurysm (HP:0004944) | 2.55635164 |
54 | Premature rupture of membranes (HP:0001788) | 2.49596634 |
55 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.47807668 |
56 | Type 1 muscle fiber predominance (HP:0003803) | 2.38954716 |
57 | Dysdiadochokinesis (HP:0002075) | 2.38294624 |
58 | Vascular tortuosity (HP:0004948) | 2.35202751 |
59 | Visual hallucinations (HP:0002367) | 2.33311707 |
60 | Left ventricular hypertrophy (HP:0001712) | 2.33126035 |
61 | Pheochromocytoma (HP:0002666) | 2.31973598 |
62 | Arterial tortuosity (HP:0005116) | 2.28863405 |
63 | Ankle clonus (HP:0011448) | 2.25914698 |
64 | Obstructive sleep apnea (HP:0002870) | 2.18183210 |
65 | Frequent falls (HP:0002359) | 2.17768835 |
66 | Hemiplegia (HP:0002301) | 2.16490178 |
67 | Rimmed vacuoles (HP:0003805) | 2.14844720 |
68 | Progressive cerebellar ataxia (HP:0002073) | 2.13912817 |
69 | Ulnar deviation of the wrist (HP:0003049) | 2.11709771 |
70 | Neck muscle weakness (HP:0000467) | 2.11418102 |
71 | Slender build (HP:0001533) | 2.09611311 |
72 | Limb-girdle muscle atrophy (HP:0003797) | 1.97700666 |
73 | Aortic dissection (HP:0002647) | 1.97664894 |
74 | Hypoglycemic coma (HP:0001325) | 1.96443142 |
75 | Sudden cardiac death (HP:0001645) | 1.96329212 |
76 | EMG: neuropathic changes (HP:0003445) | 1.94787241 |
77 | Palmoplantar keratoderma (HP:0000982) | 1.94136480 |
78 | Gaze-evoked nystagmus (HP:0000640) | 1.94028295 |
79 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.93789524 |
80 | Muscle fiber inclusion bodies (HP:0100299) | 1.93776206 |
81 | Hypoplastic ischia (HP:0003175) | 1.93232829 |
82 | Neuroendocrine neoplasm (HP:0100634) | 1.92386221 |
83 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.91966941 |
84 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.91935891 |
85 | Scapular winging (HP:0003691) | 1.90256294 |
86 | Focal motor seizures (HP:0011153) | 1.88985336 |
87 | Slow progression (HP:0003677) | 1.88763820 |
88 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.88150619 |
89 | Supranuclear gaze palsy (HP:0000605) | 1.87204528 |
90 | Hamartoma of the eye (HP:0010568) | 1.87158578 |
91 | Abnormality of the foot musculature (HP:0001436) | 1.86905152 |
92 | Rapidly progressive (HP:0003678) | 1.86040666 |
93 | Bulbar palsy (HP:0001283) | 1.85093539 |
94 | Aneurysm (HP:0002617) | 1.84980856 |
95 | Dysmetria (HP:0001310) | 1.84677588 |
96 | Conjunctival hamartoma (HP:0100780) | 1.84635276 |
97 | Foot dorsiflexor weakness (HP:0009027) | 1.83647002 |
98 | Calcaneovalgus deformity (HP:0001848) | 1.83297842 |
99 | Ketosis (HP:0001946) | 1.83228900 |
100 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.82925049 |
101 | Gowers sign (HP:0003391) | 1.82524939 |
102 | Truncal ataxia (HP:0002078) | 1.81353254 |
103 | Absence seizures (HP:0002121) | 1.80705649 |
104 | Scanning speech (HP:0002168) | 1.80584985 |
105 | Resting tremor (HP:0002322) | 1.79894157 |
106 | Athetosis (HP:0002305) | 1.78827810 |
107 | Large for gestational age (HP:0001520) | 1.73813113 |
108 | Facial diplegia (HP:0001349) | 1.73603394 |
109 | Distal lower limb amyotrophy (HP:0008944) | 1.71809457 |
110 | Intention tremor (HP:0002080) | 1.71533937 |
111 | Acute necrotizing encephalopathy (HP:0006965) | 1.71453611 |
112 | Myokymia (HP:0002411) | 1.71147735 |
113 | Depression (HP:0000716) | 1.70723966 |
114 | Focal seizures (HP:0007359) | 1.70495339 |
115 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.69679943 |
116 | Lower limb amyotrophy (HP:0007210) | 1.69415232 |
117 | Proximal amyotrophy (HP:0007126) | 1.68587817 |
118 | Distal lower limb muscle weakness (HP:0009053) | 1.67626900 |
119 | Central scotoma (HP:0000603) | 1.66664788 |
120 | Muscular dystrophy (HP:0003560) | 1.66189039 |
121 | Achilles tendon contracture (HP:0001771) | 1.66008209 |
122 | Abnormality of the ischium (HP:0003174) | 1.65516968 |
123 | Generalized muscle weakness (HP:0003324) | 1.64862237 |
124 | Termporal pattern (HP:0011008) | 1.64536551 |
125 | Insidious onset (HP:0003587) | 1.64536551 |
126 | Cerebral inclusion bodies (HP:0100314) | 1.63534057 |
127 | Cerebral hemorrhage (HP:0001342) | 1.63336918 |
128 | Tinnitus (HP:0000360) | 1.62494433 |
129 | Broad-based gait (HP:0002136) | 1.62150567 |
130 | Congestive heart failure (HP:0001635) | 1.61915147 |
131 | Impaired social interactions (HP:0000735) | 1.61796150 |
132 | Abnormal social behavior (HP:0012433) | 1.61796150 |
133 | Upper limb amyotrophy (HP:0009129) | 1.61257756 |
134 | Distal upper limb amyotrophy (HP:0007149) | 1.61257756 |
135 | Shallow orbits (HP:0000586) | 1.61003086 |
136 | Areflexia of lower limbs (HP:0002522) | 1.60743861 |
137 | Lymphangioma (HP:0100764) | 1.60732999 |
138 | Bradycardia (HP:0001662) | 1.59594761 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TTN | 4.23452059 |
2 | PHKG1 | 3.22676307 |
3 | PHKG2 | 3.22676307 |
4 | LMTK2 | 3.00950809 |
5 | RIPK1 | 2.83160268 |
6 | TRIB3 | 2.77225806 |
7 | PDK3 | 2.68947823 |
8 | PDK4 | 2.68947823 |
9 | DMPK | 2.52167076 |
10 | MYLK | 2.42929833 |
11 | OBSCN | 2.40975527 |
12 | ARAF | 2.14973769 |
13 | PKN2 | 2.12482204 |
14 | WNK1 | 2.06510827 |
15 | PRPF4B | 1.90665687 |
16 | TIE1 | 1.87445871 |
17 | PINK1 | 1.85313644 |
18 | CAMKK2 | 1.75641202 |
19 | PDK2 | 1.75424131 |
20 | STK38 | 1.65105777 |
21 | PIK3CA | 1.60929404 |
22 | EPHA4 | 1.59691337 |
23 | WNK4 | 1.51773241 |
24 | PRKD3 | 1.45646372 |
25 | PAK3 | 1.43514409 |
26 | GRK5 | 1.42923536 |
27 | CAMK2D | 1.38565417 |
28 | EPHB1 | 1.36101122 |
29 | BCKDK | 1.36080006 |
30 | NEK1 | 1.35305336 |
31 | STK39 | 1.32324760 |
32 | PAK6 | 1.31032292 |
33 | CAMKK1 | 1.26573664 |
34 | PTK6 | 1.25686520 |
35 | PRKD1 | 1.24493368 |
36 | MAP3K12 | 1.24043706 |
37 | KSR1 | 1.23967869 |
38 | CDC42BPA | 1.21465624 |
39 | MAP3K9 | 1.19775756 |
40 | EEF2K | 1.19343666 |
41 | PDGFRA | 1.09815849 |
42 | LIMK1 | 1.08480729 |
43 | MAP3K4 | 1.07147505 |
44 | PRKCH | 1.02995503 |
45 | MAP3K7 | 1.00917033 |
46 | MOS | 1.00866203 |
47 | PIK3CG | 0.99262547 |
48 | ICK | 0.99055166 |
49 | MAP2K4 | 0.97845201 |
50 | KSR2 | 0.94889813 |
51 | MAPK12 | 0.92583580 |
52 | BRAF | 0.92384249 |
53 | MUSK | 0.92005382 |
54 | MAP3K13 | 0.91621336 |
55 | CAMK4 | 0.91483876 |
56 | TESK1 | 0.89807791 |
57 | ROCK2 | 0.89236511 |
58 | CAMK1G | 0.88654063 |
59 | PDPK1 | 0.87993506 |
60 | NTRK3 | 0.87008815 |
61 | PTK2B | 0.84038405 |
62 | STK24 | 0.83601837 |
63 | CAMK1 | 0.83237997 |
64 | ROCK1 | 0.82786523 |
65 | DDR2 | 0.82774241 |
66 | PRKAA1 | 0.81678200 |
67 | RET | 0.79806815 |
68 | CAMK2G | 0.79654000 |
69 | CAMK2A | 0.79428989 |
70 | PKN1 | 0.78298861 |
71 | RAF1 | 0.77536928 |
72 | ILK | 0.74714667 |
73 | PDK1 | 0.74589044 |
74 | LATS2 | 0.70033020 |
75 | PAK2 | 0.69975433 |
76 | MAP3K6 | 0.69901072 |
77 | STK11 | 0.69357895 |
78 | PRKAA2 | 0.68892336 |
79 | DAPK3 | 0.68553928 |
80 | SGK3 | 0.68011023 |
81 | GRK7 | 0.67627152 |
82 | MAP3K3 | 0.66754779 |
83 | NEK9 | 0.66126145 |
84 | MAP2K1 | 0.65743811 |
85 | SGK223 | 0.64226572 |
86 | SGK494 | 0.64226572 |
87 | SMG1 | 0.64070572 |
88 | TGFBR2 | 0.62179241 |
89 | PTK2 | 0.61670898 |
90 | TYRO3 | 0.61224497 |
91 | MINK1 | 0.60300939 |
92 | FER | 0.59838985 |
93 | OXSR1 | 0.59735166 |
94 | IRAK2 | 0.57792584 |
95 | INSRR | 0.57105736 |
96 | PAK4 | 0.55633254 |
97 | NTRK1 | 0.54449032 |
98 | MAP2K3 | 0.54236530 |
99 | CAMK2B | 0.53052034 |
100 | DAPK2 | 0.53018273 |
101 | AKT3 | 0.52916333 |
102 | PRKCE | 0.51938501 |
103 | PRKACB | 0.51832944 |
104 | DYRK1B | 0.51108575 |
105 | EPHB2 | 0.50929773 |
106 | RPS6KA2 | 0.50110827 |
107 | MTOR | 0.49252412 |
108 | ALK | 0.48700082 |
109 | UHMK1 | 0.48528509 |
110 | CDK5 | 0.48058218 |
111 | TAOK2 | 0.47836299 |
112 | NTRK2 | 0.47628416 |
113 | MAPK4 | 0.46872773 |
114 | PRKACA | 0.46398912 |
115 | MAPK10 | 0.45892300 |
116 | CDK15 | 0.45022605 |
117 | CAMK1D | 0.44943265 |
118 | PRKACG | 0.44891641 |
119 | SIK1 | 0.44719869 |
120 | CDK18 | 0.44251021 |
121 | SGK1 | 0.43996476 |
122 | TAOK1 | 0.43572289 |
123 | MAP3K1 | 0.42372696 |
124 | TRPM7 | 0.42116805 |
125 | PRKG1 | 0.41776761 |
126 | MAP3K2 | 0.41328443 |
127 | MAPK7 | 0.40996117 |
128 | AKT2 | 0.40896885 |
129 | SGK2 | 0.39613575 |
130 | PRKG2 | 0.38748876 |
131 | MARK2 | 0.38551023 |
132 | PNCK | 0.37998231 |
133 | RPS6KA3 | 0.37844608 |
134 | PDGFRB | 0.36466421 |
135 | MARK1 | 0.36278805 |
136 | PRKCG | 0.33047207 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.73252965 |
2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.10292171 |
3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.82068637 |
4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.66235132 |
5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.53102908 |
6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.12918732 |
7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.02498913 |
8 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.99767808 |
9 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.97663889 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.75293910 |
11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.59081693 |
12 | Circadian entrainment_Homo sapiens_hsa04713 | 1.54407103 |
13 | Nicotine addiction_Homo sapiens_hsa05033 | 1.52963822 |
14 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.52319041 |
15 | Parkinsons disease_Homo sapiens_hsa05012 | 1.50639053 |
16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.50224586 |
17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.50130742 |
18 | Long-term potentiation_Homo sapiens_hsa04720 | 1.45920893 |
19 | Alzheimers disease_Homo sapiens_hsa05010 | 1.44775574 |
20 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.44488669 |
21 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.41980469 |
22 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.41386706 |
23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.40643878 |
24 | Carbon metabolism_Homo sapiens_hsa01200 | 1.38229677 |
25 | Salivary secretion_Homo sapiens_hsa04970 | 1.34264755 |
26 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.33997206 |
27 | GABAergic synapse_Homo sapiens_hsa04727 | 1.32110505 |
28 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.29940899 |
29 | Insulin secretion_Homo sapiens_hsa04911 | 1.28565229 |
30 | Taste transduction_Homo sapiens_hsa04742 | 1.25965719 |
31 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.23964274 |
32 | Glioma_Homo sapiens_hsa05214 | 1.22734382 |
33 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.22331010 |
34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.21408718 |
35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.20921085 |
36 | Renin secretion_Homo sapiens_hsa04924 | 1.20268470 |
37 | Morphine addiction_Homo sapiens_hsa05032 | 1.18523686 |
38 | Long-term depression_Homo sapiens_hsa04730 | 1.18038070 |
39 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.09191966 |
40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.08061833 |
41 | Prion diseases_Homo sapiens_hsa05020 | 1.03899909 |
42 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.03063861 |
43 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.01804090 |
44 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.01574574 |
45 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.99233701 |
46 | Endometrial cancer_Homo sapiens_hsa05213 | 0.98937711 |
47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.98654100 |
48 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.97922295 |
49 | Adherens junction_Homo sapiens_hsa04520 | 0.96363625 |
50 | Platelet activation_Homo sapiens_hsa04611 | 0.96054061 |
51 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.95813255 |
52 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.95435412 |
53 | Bile secretion_Homo sapiens_hsa04976 | 0.95092888 |
54 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.94394837 |
55 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.92671886 |
56 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.91650981 |
57 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.91173538 |
58 | Huntingtons disease_Homo sapiens_hsa05016 | 0.88692777 |
59 | Gap junction_Homo sapiens_hsa04540 | 0.87220358 |
60 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.87149116 |
61 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.86615965 |
62 | Insulin resistance_Homo sapiens_hsa04931 | 0.86374316 |
63 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.85418592 |
64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84877364 |
65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84828654 |
66 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.84790916 |
67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84468417 |
68 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.83670050 |
69 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.83227537 |
70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80006978 |
71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.79446065 |
72 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.79090684 |
73 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.78916444 |
74 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77928940 |
75 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.77430259 |
76 | Focal adhesion_Homo sapiens_hsa04510 | 0.77268802 |
77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76772074 |
78 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.75678073 |
79 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.75593300 |
80 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.75045440 |
81 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.72674475 |
82 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.70856012 |
83 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.70267335 |
84 | Olfactory transduction_Homo sapiens_hsa04740 | 0.70183510 |
85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.69946543 |
86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69813549 |
87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69785245 |
88 | Tight junction_Homo sapiens_hsa04530 | 0.68992903 |
89 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.68586119 |
90 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.68512212 |
91 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.68059962 |
92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68012637 |
93 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67575186 |
94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65468294 |
95 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.64509544 |
96 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63802666 |
97 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.62974634 |
98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.62670806 |
99 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62577202 |
100 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60725235 |
101 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60178296 |
102 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58810997 |
103 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58694152 |
104 | Endocytosis_Homo sapiens_hsa04144 | 0.57423036 |
105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56243985 |
106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56149445 |
107 | Axon guidance_Homo sapiens_hsa04360 | 0.54125887 |
108 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.53263734 |
109 | * Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52352284 |
110 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.51824926 |
111 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.51586211 |
112 | Circadian rhythm_Homo sapiens_hsa04710 | 0.51451429 |
113 | Lysine degradation_Homo sapiens_hsa00310 | 0.50314183 |
114 | Amoebiasis_Homo sapiens_hsa05146 | 0.49761277 |
115 | Melanogenesis_Homo sapiens_hsa04916 | 0.48956157 |
116 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.48842681 |
117 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.48664491 |
118 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47498005 |
119 | Cocaine addiction_Homo sapiens_hsa05030 | 0.47139256 |
120 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.46722178 |
121 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.46369924 |
122 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45675557 |
123 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45362814 |
124 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.42918249 |
125 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41645196 |
126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41601280 |
127 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41441546 |
128 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.40805577 |
129 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.38847042 |
130 | Mineral absorption_Homo sapiens_hsa04978 | 0.38577330 |